Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical trials

Appointment underscores Qureight’s commitment to drive adoption of its AI-powered imaging and clinical data curation platform to support clinical trials and accelerate drug development timelines for lung and heart diseases.

Paragraf pioneers graphene-based electronics with standard semiconductor processes, producing magnetic sensors and GMS while developing advanced devices.

The trial is a component of the Accelerating Medicines Partnership Schizophrenia programme, managed by FNIH.

Dynamic tech duo Rupert Baines and former chair Phil O'Donovan have been unveiled as a new executive leadership team to spearhead a fresh push for global growth by Cambridge fabless semiconductor company Forefront RF.

Industry-leaders Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) appointed as Chair and Non-Executive Director, respectively

Thought Machine, a cloud-native banking technology company, has partnered with Zopa Bank to launch its current bank account Biscuit.

Cambridge-based materials innovation company, Xampla, has heralded a major commercial advance as Bunzl UK & Ireland adds Huhtamaki’s ‘Taste’ hot food boxes with Morro Coating to its comprehensive range of food service packaging.

Cotton Mouton Diagnostics, a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises, the investment arm of CPI, as part of the Innovate UK Catapult Associated Fund.

Qureight, a techbio company accelerating drug development using its proprietary deep-learning image biomarkers and clinical data analytics platform, today announced the first results from a collaboration with Insilico Medicine (“Insilico”), a clinical-stage biotechnology company driven by generative AI, focused on rentosertib (ISM001-055), a novel TNIK inhibitor discovered using Insilico's generative AI approach, in development for the treatment of IPF.

ZeroRISC, a leader in open-source silicon supply chain integrity, has appointed Zakir Durumeric, Stanford Professor and Censys Founder, and David Gammon, CEO and founder of Rockspring, to its Board of Directors.

A $40 million London-based fund backed by the Christopher & Dana Reeve Foundation, among others, today unveils its first major investment – and Cambridge AI drug discovery company Healx is the beneficiary.